Passave postpones Nasdaq IPO

In a filing two weeks ago, the company said it planned to raise about $68m. at a market capitalization of $185m.-$209m.

November 8, 2005 07:02
1 minute read.
passave logo 88

passave logo 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Israeli semiconductor developer Passave has postponed its initial public offering on Nasdaq due to legal proceedings, making it the second Israeli company in as many weeks to delay or cancel a listing on the US exchange. Passave was supposed to have carried out its IPO this week and was in the middle of a road show, a source close to the situation said on Monday. The company hoped to solve what the source called "a legal technical problem" in the coming weeks and proceed with the listing. "There is a good chance that the IPO will happen by the end of the year," the source said. In a filing two weeks ago, the Herzliya Pituah-based company said it planned to raise about $68 million at a market capitalization of $185m.-$209m. It was to offer 4.7 million shares at $15-$17 each with an overallotment option of 705,000 shares. The source said that when the IPO did go ahead, the conditions would be broadly the same, but would ultimately depend on the market. The company develops "system-on-a-chip" technology for telecommunications networks, enabling service providers to offer voice, video and high-speed Internet access, or "triple-play" services, over optical networks. Founded in 2001, it now has over 120 employees, including 88 in research and development, 20 in sales and marketing and 18 in general and administration. Passave isn't the only company to have run into problems with a US IPO recently. At the end of last month, Ramat Gan-based Predix Pharmaceuticals withdrew its filing to list on Nasdaq, citing "unfavorable market conditions." The company was planning to raise about $50m.

More about:NASDAQ

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings